Cargando…
MiR145-5p inhibits proliferation of PMVECs via PAI-1 in experimental hepatopulmonary syndrome rat pulmonary microvascular hyperplasia
Hepatopulmonary syndrome (HPS) is a triad of advanced liver disease, intrapulmonary vasodilatation and arterial hypoxemia. Increasing evidence shows that HPS is associated with pulmonary microvascular hyperplasia. The aim of this work was to investigate the underlying mechanism of miR-145 in regulat...
Autores principales: | Chen, Yang, Yang, Congwen, Li, Yujie, Chen, Lin, Yang, Yong, Belguise, Karine, Wang, Xiaobo, Lu, Kaizhi, Yi, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899039/ https://www.ncbi.nlm.nih.gov/pubmed/31649116 http://dx.doi.org/10.1242/bio.044800 |
Ejemplares similares
-
Inhibition of autophagy ameliorates pulmonary microvascular dilation and PMVECs excessive proliferation in rat experimental hepatopulmonary syndrome
por: Xu, Duo, et al.
Publicado: (2016) -
Hepatocyte-derived exosomal MiR-194 activates PMVECs and promotes angiogenesis in hepatopulmonary syndrome
por: Chen, Lin, et al.
Publicado: (2019) -
Loss of cell polarity regulated by PTEN/Cdc42 enrolled in the process of Hepatopulmonary Syndrome
por: Gao, Jing, et al.
Publicado: (2019) -
MiR181-5p promotes pathogenic angiogenesis of hepatopulmonary syndrome by negatively regulating Wnt inhibitor Wif1
por: Li, Dan, et al.
Publicado: (2023) -
Krüppel-like factor 6 mediates pulmonary angiogenesis in rat experimental hepatopulmonary syndrome and is aggravated by bone morphogenetic protein 9
por: Yang, Yihui, et al.
Publicado: (2019)